AzzopardiJ. G.LehnerT. (1966). Systemic amyloidosis and malignant disease. J. clin. Path., 19, 539.
2.
BayrdE. D. (1961). Continuous chlorambucil therapy in primary macroglobulinaemia: Report of four cases. Proc. Mayo Clinic, 36, 135.
3.
BingJ.NeelA. V. (1936). Two cases of hyperglobulinaemia with affection of the central nervous system of a toxi-infectious basis. Acta med. scand., 88, 492.
4.
Bulletin of the World Health Organisation (1964). Nomenclature for human immunoglobulins. Bull. Wld. Hlth. Org., 30, 447.
5.
HumeR.GoldbergA.GarvieD. G. (1961). Steroid therapy in multiple myeloma. Scot. med. J., 6, 189.
6.
LogethetisJ.SilversteinP.CoeJ. (1960). Neurologic aspects of Waldenstrom's macroglobulinaemia. AMA Arch. Neurol.3, 564.
7.
MartinW. H. (1960). Macroglobulinaemia. Quart. J. Med., 105, 939.
8.
MartinW. H.CloseH. G. (1957). Macroglobulinaemia. Lancet, 2, 8.
9.
OssermanE. F. (1961). The plasmocytic dyscrasias; plasma cell myeloma and primary macroglobulinaemia. Amer. J. Med., 31, 671.
10.
OssermanE. F.TakatsukiK. (1963). Plasma cell myeloma: Gamma globulin synthesis and structure. Medicine (Baltimore), 42, 357.
11.
RitzmanS. E.ThurmR. H.TruaxW. E.LevinW. C. (1960). The syndrome of macroglobulinaemia. Arch. intern. Med., 105, 939.
12.
WaldenströmJ. (1944). Incipient myelomatosis of “essential” hyperglobulinaemia with fibrogenopenia: A new syndrome?Acta med. scand., 117, 216.
13.
WaldenströmJ. (1948). Zwei interessante Syndrome mit Hyperglobulinaemie (Purpura hyperglobulinaemie und macroglobulinaemie). Schweiz. med. Wchnschr., 78, 1927.
